Literature DB >> 10589701

Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases.

D Suzuki1, T Miyata, M Nangaku, H Takano, N Saotome, M Toyoda, Y Mori, S Y Zhang, R Inagi, M Endoh, K Kurokawa, H Sakai.   

Abstract

Mesangial cells play an important role in maintaining a structure and function of the glomerulus and in the pathogenesis of glomerular diseases. Recently, we discovered a new mesangium-predominant gene termed "megsin." Megsin is a novel protein that belongs to the serine protease inhibitor (serpin) superfamily. To elucidate the pathophysiologic role of megsin in the kidney, the expression and localization of megsin mRNA in renal tissues of patients with IgA nephropathy (IgA-N), diabetic nephropathy (DN), minimal change nephrotic syndrome (MCNS), membranous nephropathy (MN), and normal human kidney (NHK) was evaluated by in situ hybridization using digoxigenin-labeled oligonucleotide. Individual cells positive for megsin mRNA were observed only in glomeruli in all renal tissues. Their localization coincided with those of mesangial cells. The percentage of positive cells for megsin mRNA in total glomerular cells was significantly greater in IgA-N than in MCNS, MN, and NHK. It was also significantly greater in DN than in MCNS and NHK. In IgA-N, the percentage of megsin mRNA-positive cells was greater in tissues from those with mesangial cell proliferation and slightly mesangial matrix expansion (periodic acid-Schiff-positive area in the total glomerulus area, <30%; cell number in mesangial matrix area, >30; assessed in cross-sections through their vascular poles) than in tissues from those with severe mesangial matrix expansion (periodic acid-Schiff-positive area in total glomerulus area, >30%; cell number in mesangial matrix area, <30). In conclusion, megsin mRNA was predominantly expressed in glomerular mesangial cells in all renal tissues. The expression of megsin mRNA was upregulated in IgA-N and DN, both of which are diseases accompanied with mesangial cell proliferation and/or mesangial matrix expansion. These data suggest a link of megsin expression to the pathogenesis of IgA-N and DN, two major causes of end-stage renal failure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10589701     DOI: 10.1681/ASN.V10122606

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  10 in total

Review 1.  Hepatic fibrosis and carcinogenesis in α1-antitrypsin deficiency: a prototype for chronic tissue damage in gain-of-function disorders.

Authors:  David H Perlmutter; Gary A Silverman
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

2.  Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion.

Authors:  Toshio Miyata; Reiko Inagi; Masaomi Nangaku; Toshiyuki Imasawa; Masahiro Sato; Yuko Izuhara; Daisuke Suzuki; Atsusi Yoshino; Hiroshi Onogi; Minoru Kimura; Satoshi Sugiyama; Kiyoshi Kurokawa
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor.

Authors:  Masao Kakoki; Nobuyuki Takahashi; J Charles Jennette; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

4.  Megsin gene: its genomic analysis, pathobiological functions, and therapeutic perspectives.

Authors:  Toshio Miyata; Ming Li; Xueqing Yu; Noriaki Hirayama
Journal:  Curr Genomics       Date:  2007-05       Impact factor: 2.236

Review 5.  The kallikrein-kinin system in diabetic nephropathy.

Authors:  Hirofumi Tomita; Ryan B Sanford; Oliver Smithies; Masao Kakoki
Journal:  Kidney Int       Date:  2012-02-08       Impact factor: 10.612

Review 6.  Genetics and immunopathogenesis of IgA nephropathy.

Authors:  Hsin-Hui Yu; Kuan-Hua Chu; Yao-Hsu Yang; Jyh-Hong Lee; Li-Chieh Wang; Yu-Tsan Lin; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 10.817

7.  A Reduction-Based Sensor for Acrolein Conjugates with the Inexpensive Nitrobenzene as an Alternative to Monoclonal Antibody.

Authors:  Masayuki Takamatsu; Koichi Fukase; Ritsuko Oka; Shinobu Kitazume; Naoyuki Taniguchi; Katsunori Tanaka
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

8.  Integrated genomic, transcriptomic and metabolomic analysis reveals MDH2 mutation-induced metabolic disorder in recurrent focal segmental glomerulosclerosis.

Authors:  Qixia Shen; Lisha Teng; Yucheng Wang; Luying Guo; Feng Xu; Hongfeng Huang; Wenqing Xie; Qin Zhou; Ying Chen; Junwen Wang; Youying Mao; Jianghua Chen; Hong Jiang
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

9.  Association of Megsin Gene Variants With IgA Nephropathy in Northwest Chinese Population: A STROBE-Compliant Observational Study.

Authors:  Lin-Ting Wei; Rong-Guo Fu; Jie Gao; Qiao-Ling Yu; Feng-Ming Dong; Zhe Wang; Meng Wang; Xing-Han Liu; Zhi-Jun Dai
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

10.  SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment.

Authors:  Daniela Bianconi; Merima Herac; Daniel Spies; Markus Kieler; Robert Brettner; Matthias Unseld; Katrin Fürnkranz; Barbara Famler; Margit Schmeidl; Christoph Minichsdorfer; Christoph Zielinski; Gerwin Heller; Gerald W Prager
Journal:  Transl Oncol       Date:  2018-09-20       Impact factor: 4.243

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.